Desjardins Global Asset Management’s AbbVie ABBV Stock Holding History

Desjardins Global Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$2.24M	Buy	14,469 +181	+1%	+$26.4K	0.24%	91
2023 Q3	$2.13M	Sell	14,288 -4,318	-23%	-$634K	0.23%	88
2023 Q2	$2.51M	Buy	18,606 +5,339	+40%	+$783K	0.29%	73
2023 Q1	$2.11M	Buy	13,267 +7,755	+141%	+$1.19M	0.27%	74
2022 Q4	$890K	Buy	5,512 +140	+3%	+$21.5K	0.14%	149
2022 Q3	$720K	Buy	5,372 +174	+3%	+$25K	0.09%	189
2022 Q2	$796K	Sell	5,198 -403	-7%	-$61.6K	0.1%	176
2022 Q1	$907K	Sell	5,601 -211	-4%	-$30.6K	0.08%	196
2021 Q4	$786K	Buy	+5,812	New	+$687K	0.07%	225

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Desjardins Global Asset Management's ABBV Position: Q4 2023 in Review

Desjardins Global Asset Management increased its AbbVie (ABBV) stake by 1.3% in Q4 2023, buying an estimated $26.4K and bringing the position to 14,469 shares worth $2.24M. The position accounts for 0.24% of the portfolio, ranked #91.

Desjardins Global Asset Management first reported a position in ABBV in Q4 2021 and has held it in 9 quarters since. The position peaked at $2.51M in Q2 2023. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

Desjardins Global Asset Management held 14,469 shares of AbbVie worth $2.24M as of Q4 2023.
Desjardins Global Asset Management bought 181 AbbVie shares in Q4 2023, an estimated $26.4K.
AbbVie made up 0.24% of Desjardins Global Asset Management's portfolio in Q4 2023, its #91 holding.
Desjardins Global Asset Management first reported a position in AbbVie in Q4 2021 and has held it in 9 quarters since.
Desjardins Global Asset Management's AbbVie position peaked at $2.51M in Q2 2023.
3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.